Xiaolin Zhang
Tracked across 3 events · 20 articles · First seen May 31, 2026 · Last active Sep 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: As CEO of Dizal Pharmaceutical, Dr. Xiaolin Zhang's statements highlight the significance of the clinical data and the company's commitment to addressing unmet medical needs.
May 31, 2026 · 6 articles
Business
Impact: As CEO of Dizal Pharmaceutical, he expressed confidence in AstraZeneca's ability to globalize Zegfrovy.
Jul 14, 2026 · 8 articles
Business
Impact: Xiaolin Zhang, Dizal's CEO, commented on the deal, but has no direct financial impact.
Sep 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Xiaolin Zhang live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard